Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.83%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 6.42Close
$ 4.4 - $ 34 52-Week Range
Ticker Information
Ticker
BDSXCompany Name
BIODESIX INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQBIODESIX INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BDSX - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1.4M | 1.83% | $ 76.56M |
| 3/31/2025 | $ 3.3M | 4.44% | $ 74.46M |
| 12/31/2024 | $ 3.44M | 4.82% | $ 71.32M |
| 9/30/2024 | $ 5.56M | 8.48% | $ 65.56M |
| 6/30/2024 | $ 11.15M | 18.31% | $ 60.9M |
| 3/31/2024 | $ 15.63M | 28.49% | $ 54.85M |
| 12/31/2023 | $ 23.06M | 46.98% | $ 49.09M |
| 9/30/2023 | $ 22.05M | 50.08% | $ 44.03M |
| 6/30/2023 | $ 16.98M | 40.78% | $ 41.64M |
| 3/31/2023 | $ 10.89M | 26.74% | $ 40.72M |
Key Performance Insights, Last 5 Years
- BIODESIX INC's latest trailing twelve months (TTM) CapEx % stands at 5.77%.
- Over the past 5 years, BIODESIX INC's average CapEx % has been 14.92%.
- The median CapEx % for BIODESIX INC during this period was 7.4%
- BIODESIX INC reached its highest CapEx % over the past 5 years at 50.08%.
- The lowest CapEx % recorded by BIODESIX INC in the same timeframe 1.83%
BIODESIX INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for BIODESIX INC is calculated as follows: CapEx [ $ 1.42M ] / Revenues [ $ 24.55M ]
(=) CapEx % [ 5.77% ] BDSX - Capital Expenditures Margin, Last 5 years
1.83%
Minimum
Jun 30, 2025
50.08%
Maximum
Sep 30, 2023
14.92%
Average
7.4%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |